The patients were randomized into four groups: three received different doses of tirzepatide 5, 10, and 15mg per week and the fourth received 1mg semaglutide
The treatment ability to enhance glycemic control and improve lipid profiles in these individuals could significantly impact both diabetes and cardiovascular disease outcomes in overweight and obese populations
Figure 5 GI symptoms, including anorectal dysfunction such as constipation and fecal incontinence, are commonly reported in MS, affecting approximately 40% of patients (Nusrat et al., 2012)
By taking Mounjaro alongside HRT, women may be able to better counteract some of these menopausal effects: Mounjaros appetite-lowering effect could help overcome increased hunger and food cravings The metabolic benefits of HRT may complement Mounjaros fat-burning effects HRT may help mitigate some of the negative impacts of oestrogen decline on body composition The study published in Menopause found that combining a GLP-1 medication (similar to Mounjaro) and HRT led to an average weight loss of 16%, compared to 12% for those not using HRT
Insurance verification assistance available
We track your response closely and adjust the plan to support sustainable fat loss and overall health markers